1
Clinical Trials associated with BIBR-1017-BSSafety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BIRB 1017 BS (5, 25, 100, 250, 500, and 800 mg) as a Solution in PEG 400 / 26% Ethanol Administered to Healthy Male Subjects. Placebo Controlled and Blinded at Each Dose Level
Study to assess safety, tolerability and pharmacokinetics of BIRB 1017 BS in single rising oral doses of 5 to 800 mg in a polyethylene glycol 400 (PEG 400) / 26% ethanol solution in healthy male subjects
100 Clinical Results associated with BIBR-1017-BS
100 Translational Medicine associated with BIBR-1017-BS
100 Patents (Medical) associated with BIBR-1017-BS
100 Deals associated with BIBR-1017-BS